Moscow City Hall sees no risks in building an AstraZeneca pharmaceutical plant in the capital.
The project to create a pharmaceutical plant for AstraZeneca in Moscow is important and relevant for Russia, there are no risks in this project, the capital's head of investment and industrial policy Anatoly Garbozov said at a press conference.